Detalhe da pesquisa
1.
Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Int J Gynecol Pathol
; 42(4): 403-413, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305517
2.
Endogenous Retrovirus RNA Expression Differences between Race, Stage and HPV Status Offer Improved Prognostication among Women with Cervical Cancer.
Int J Mol Sci
; 24(2)2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675007
3.
Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis.
Gynecol Oncol
; 163(1): 162-170, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446269
4.
Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.
Int J Gynecol Cancer
; 30(6): 772-776, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156714
5.
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery.
Int J Gynecol Cancer
; 29(7): 1156-1163, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352365
6.
Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.
Oncologist
; 21(5): 576-85, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026677
7.
Perineal body stretch during labor does not predict perineal laceration, postpartum incontinence, or postpartum sexual function: a cohort study.
Int Urogynecol J
; 27(8): 1193-200, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26874524
8.
Erratum to "Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival" [Gynecol. Oncol. 155 (2019) 483-488].
Gynecol Oncol
; 157(1): 299, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059865
9.
Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival.
Gynecol Oncol
; 155(3): 483-488, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31653509
10.
Tolerance of Olaparib in a Patient With Unresectable Serous Gynecologic Cancer and End-Stage Renal Disease.
Cureus
; 15(3): e36505, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090414
11.
The impact of adjuvant antihormonal therapy versus observation on recurrence of borderline ovarian tumors: A retrospective cohort study.
Gynecol Oncol Rep
; 47: 101180, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096018
12.
Does Lymph Node Dissection Impact Adjuvant Treatment or Survival Outcomes in High-Risk Endometrial Cancers?
Cureus
; 14(5): e24710, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35663703
13.
Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies.
Front Oncol
; 10: 598579, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415077
14.
Germline and Somatic Tumor Testing in Gynecologic Cancer Care.
Obstet Gynecol Clin North Am
; 46(1): 37-53, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683265
15.
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers.
Gynecol Oncol Res Pract
; 4: 17, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29093822